Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1

被引：0
|
作者：
Y Akashi
T Oda
Y Ohara
R Miyamoto
T Kurokawa
S Hashimoto
T Enomoto
K Yamada
M Satake
N Ohkohchi
机构：
[1] Clinical Sciences,Department of Surgery
[2] Graduate School of Comprehensive Human Sciences,Department of Diagnostic Radiology
[3] University of Tsukuba,undefined
[4] 1-1-1 Tennoudai,undefined
[5] Tsukuba,undefined
[6] 305-8575 Ibaraki,undefined
[7] Japan,undefined
[8] Research Center for Innovative Oncology,undefined
[9] National Cancer Center Hospital East,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
gemcitabine; iRGD peptide; neuropilin-1; pancreatic cancer; tumour graft;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1481 / 1487
页数：6
相关论文
共 18 条
  • [11] Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study
    Dean, Andrew
    Gill, Sanjeev
    McGregor, Mark
    Broadbridge, Vy
    Jarvelainen, Harri A.
    Price, Timothy
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (10): : 943 - 951
  • [12] Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis
    Ho, Tuyen Thuy Bich
    Nasti, Alessandro
    Seki, Akihiro
    Komura, Takuya
    Inui, Hiiro
    Kozaka, Takashi
    Kitamura, Yoji
    Shiba, Kazuhiro
    Yamashita, Taro
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Kawaguchi, Kazunori
    Wada, Takashi
    Honda, Masao
    Kaneko, Shuichi
    Sakai, Yoshio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [13] Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
    Nishikubo, Kou
    Ohgaki, Ryuichi
    Liu, Xingming
    Okanishi, Hiroki
    Xu, Minhui
    Endou, Hitoshi
    Kanai, Yoshikatsu
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [14] Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
    Kou Nishikubo
    Ryuichi Ohgaki
    Xingming Liu
    Hiroki Okanishi
    Minhui Xu
    Hitoshi Endou
    Yoshikatsu Kanai
    Cancer Cell International, 23
  • [15] THE DIFFERENTIAL BEHAVIORAL-EFFECTS OF BENZAZEPINE D-1 DOPAMINE AGONISTS WITH VARYING EFFICACIES, CO-ADMINISTERED WITH QUINPIROLE IN PRIMATE AND RODENT MODELS OF PARKINSONS-DISEASE
    GNANALINGHAM, KK
    HUNTER, AJ
    JENNER, P
    MARSDEN, CD
    PSYCHOPHARMACOLOGY, 1995, 117 (03) : 287 - 297
  • [16] Co-treatment with a C1B5 domain peptide of protein kinase Cγ and a low dose of gemcitabine effectively inhibited pancreatic cancer growth in mouse peritoneal cavity
    Zulbaran, Alejandro
    Monson, Kelsey
    Ishiguro, Susumu
    Kawabata, Atsushi
    Uppalapati, Deepthi
    Ohta, Naomi
    Tamura, Masaaki
    CANCER RESEARCH, 2017, 77
  • [17] Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation
    Ishiguro, Susumu
    Kawabata, Atsushi
    Zulbaran-Rojas, Alejandro
    Monson, Kelsey
    Uppalapati, Deepthi
    Ohta, Naomi
    Inui, Makoto
    Pappas, Charalampos G.
    Tzakos, Andreas G.
    Tamura, Masaaki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) : 962 - 968
  • [18] mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53flox/+LSL-KrasG12D/+Pdx-1-Cre murine models
    Qiu, Jiangdong
    Feng, Mengyu
    Yang, Gang
    Cao, Zhe
    Liu, Yueze
    You, Lei
    Zhang, Taiping
    CANCER LETTERS, 2023, 554
12